Form 4: Credo Technology Director Sells Over 100,000 Shares in Open Market Transactions
Insider Trading Report
Credo Technology Group Holding Ltd Director Lip-Bu Tan reported the sale of 103,527 ordinary shares across two transactions in mid-June 2025, executed under a Rule 10b5-1 trading plan.
Summary
- Lip-Bu Tan, a Director of Credo Technology Group Holding Ltd (CRDO), reported the sale of 103,527 ordinary shares in two separate transactions.
- On June 12, 2025, Mr. Tan sold 100,000 ordinary shares at a weighted average price of $75.3338 per share, with prices ranging from $75.00 to $75.80.
- On June 13, 2025, an additional 3,527 ordinary shares were sold at a weighted average price of $76.0479 per share, with prices ranging from $76.00 to $76.21.
- Both transactions were conducted pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
- Following these transactions, Mr. Tan's indirect beneficial ownership through Walden Technology Ventures Investments II, L.P. decreased from 788,725 shares to 785,198 shares.
- Mr. Tan also holds 133,583 ordinary shares indirectly through the Lip-Bu Tan and Ysa Loo Trust, 53,574 shares directly, and 39,736 shares indirectly through A&E Investment LLC.
Sentiment
Score: 3
Explanation: The sentiment is moderately negative due to a significant insider share sale, even though it was pre-planned under a 10b5-1 program. Insider selling can be interpreted as a lack of confidence or a move to diversify, which typically weighs on investor sentiment.
Positives
- The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale not based on new, non-public information, which enhances transparency and compliance.
Negatives
- A director selling a significant number of shares (103,527 shares) can be perceived negatively by investors as it reduces insider ownership and alignment with shareholder interests.
Risks
- Potential negative investor sentiment or market reaction due to insider selling, which could lead to short-term share price volatility.
- The sales, even if pre-planned, might be interpreted by some investors as a signal of reduced confidence in the company's future prospects by a key insider.
Future Outlook
This document, an SEC Form 4, reports past insider transactions and does not contain forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This Form 4 filing is a routine disclosure of insider trading activity and does not provide broader industry context or trends. It reflects an individual director's equity transactions rather than a company-wide strategic or financial update.
Related Party Transactions
- The reporting person, Lip-Bu Tan, is the Managing Director of China Walden Venture Investment II G.P., Ltd., the general partner of Walden Technology Ventures Investments II, L.P., through which a significant portion of the shares were indirectly held and sold.
- Shares are also indirectly held through the Lip-Bu Tan and Ysa Loo Trust, for which the reporting person is a joint trustee.
- Additional shares are indirectly held through A&E Investment LLC, an entity owned by the reporting person's family trust, for which the reporting person is the Manager and a joint trustee.
Stakeholder Impact
- Shareholders: May interpret the director's sale as a negative signal, potentially influencing their investment decisions or the company's stock price.
- Employees: No direct impact mentioned, but significant insider selling could indirectly affect morale if perceived as a lack of confidence by leadership.
Key Dates
| Date | Description |
|---|---|
| 06/12/2025 | Transaction date for the sale of 100,000 ordinary shares. |
| 06/13/2025 | Transaction date for the sale of 3,527 ordinary shares. |
| 06/16/2025 | Date the Form 4 filing was signed by the attorney-in-fact. |
Recommendation
holdKeywords
Credo Technology Group Holding Ltd, CRDO, SEC Form 4, Insider Trading, Share Sale, Director, Equity Transaction, Lip-Bu Tan, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.